The programme generated a substantial amount of new knowledge. Any direct application of this knowledge was not expected, as the programme ran only for a relatively short time, i.e. three years. The panel found the programme well planned and praised the programme for the its fruitful collaboration contacts. The programme was carried out in cooperation with the Swedish Foundation for Strategic Research and involved several Finnish-Swedish joint projects.
The MICMAN programme was implemented during 2003–2005. The specific objective of the programme was to increase our understanding and knowledge of the interaction between host and microbes and to apply this knowledge to the maintenance of health and to prevention and treatment of diseases.
In 2005, the Academy appointed an international expert panel to evaluate the programme. The panel was asked to assess the programme as a whole, focusing particularly on national and international cooperation, the scientific quality of research, the added value generated by the programme as well as the applicability of research results. The panel was also asked to give recommendations for the future.
The key recommendations of the panel include: to extend the programme duration to five or six years with a mid-term evaluation, to secure funding for PhD students for four years, to further strengthen international cooperation and to promote the mobility of junior researchers. The panel also recommends the launch of a new research programme with focus on innate immunity and chronic infections.
Niko Rinta | Source: alphagalileo
Further information: www.aka.fi
More articles from
Health and Medicine:
What a Sleep Study Can Reveal About Fibromyalgia
05.09.2008 | Michigan Technological University
Antioxidants - friend or foe?
04.09.2008 | Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
Theory of the sun's role in formation of the solar system questioned
05.09.2008 | Earth Sciences
Caught in a trap: bumblebees vs. robotic crab spiders
05.09.2008 | Life Sciences
Do 68 molecules hold the key to understanding disease?
05.09.2008 | Life Sciences